A patient having AIDs or undergoing chemotherapy has a compromised immune system and is very vulnerable, particularly to multi-drug–resistant fungi. As most anti-fungal drugs are severely toxic there is a large gap in a world market worth USD 4 billion annually.
For further information: cordis.europa.eu